The origin of ovarian cancer—is it getting clearer?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Circulating miRNAs as Biomarkers for Endometriosis and Endometriosis-Related Ovarian Cancer-An Overview.Journal of clinical medicine · 2019
   Review
2. Association between ovarian cancer and advanced endometriosis.Oncology letters · 2018
   Article
3. Functional analysis of miR-34c as a putative tumor suppressor in high-grade serous ovarian cancer.Biology of reproduction · 2014
   Article
4. Molecular profiling and clinical outcome of high-grade serous ovarian cancer presenting with low- versus high-volume ascites.BioMed research international · 2014
   Article
5. ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas.International journal of molecular sciences · 2013
   Review
6. Enhanced efficacy and specificity of epithelial ovarian carcinogenesis by embedding a DMBA-coated cloth strip in the ovary of rat.Journal of ovarian research · 2012
   Article
7. Proteomic characterization of ovarian cancers identifying annexin-A4, phosphoserine aminotransferase, cellular retinoic acid-binding protein 2, and serpin B5 as histology-specific biomarkers.Cancer science · 2012
   Article
8. Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features.Virchows Archiv : an international journal of pathology · 2012
   Review
9. Modulation of estrogenic action in clear cell carcinoma of the ovary (Review).Experimental and therapeutic medicine · 2012
   Article

Corrections and comments

• Comment on
  ARID1A mutations in endometriosis-associated ovarian carcinomas.2010

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as